ý

Expert Directory - Cancer Health Disparities

Showing results 1 – 2 of 2

Pamela Valera, PhD, MSW

Assistant Professor Director of Doctoral Studies Department of Urban-Global Public Health

Rutgers School of Public Health

Cancer Health Disparities, criminal justice and health, Tobacco Control

Dr. Valera is an Assistant Professor in the School of Public Health and also an Affiliated Faculty in the School of Social Work at Rutgers University. She earned her PhD in Social Work from the University of South Carolina, College of Social Work. Dr. Valera completed a three-year postdoctoral research fellowship in human immunodeficiency virus prevention and human sexuality from Columbia University and the New York State Psychiatric Institute, and a one-year clinical fellowship in cancer health disparities from the Albert Einstein College of Medicine. She has sustained several years of NIH-funded research in cancer health disparities among men with criminal justice histories at the Albert Einstein College of Medicine, Department of Epidemiology and Population Health, and Columbia University Mailman School of Public Health. In addition, Dr. Valera is a certified tobacco treatment specialist and the co-chair/co-founder of the Bronx Reentry Working Group, a coalition of returning citizens, friends, and family members supporting each other through community reintegration.

Research Interests
Dr. Valera’s research uses a public health and social work lens to explore health behaviors and health promotion strategies to reduce the detrimental effects of incarceration, cancer burden, (particularly cigarette smoking/tobacco use) and HIV in men. Specifically, she engages in scholarship that explores how situational and contextual factors influence the health of incarcerated and formerly incarcerated men. Moreover, the theoretical foundation that frames her research is rooted in public health and social work. Dr. Valera’s research falls into three broad topic areas: 1) Cancer-health disparities and incarcerated populations: Much of her scholarship in this area focuses on tobacco smoke and smoking cessation among formerly incarcerated and incarcerated men. These studies point to the urgent need to provide prison-based smoking cessation programs in criminal justice settings to reduce the detrimental effects of cigarette smoking.

Narjust Florez, MD

Associate Director of the Cancer Care Equity Program

Dana-Farber Cancer Institute

ASCO 2024, Associate Director, Cancer Care, Cancer Health Disparities, Lung Cancer, Mesothelioma, Thoracic Oncology

Dr. Narjust Florez is the Associate Director of the Cancer Care Equity Program and a thoracic medical oncologist at the Dana-Farber Brigham Cancer Center. She completed her internal medicine residency in Rutgers New Jersey Medical School and fellowship at the Mayo Clinic in Rochester, Minnesota where she was the chief fellow from 2018-2019.

Dr. Florez's clinical interests include targeted therapy for lung cancer and the care of women with lung cancer, including their unique aspects of cancer survivorship. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study, the largest study to date evaluating sexual dysfunction in women with lung cancer.

Apart from her clinical interests in lung cancer, she is also a leading and productive researcher in cancer health disparities, gender and racial discrimination in medical education and medicine. She received many awards including the 2018 Resident of the Year Award by the National Hispanic Medical Association, the Mayo Brothers Distinguished Fellowship award and the 2020 Rising Star award by the LEAD national conference for women in hematology and oncology.

In addition, Dr. Florez founded the Florez Lab in 2019. The laboratory focuses on lung cancer, social justice issues in medicine and medical education. The laboratory long-term goals are to create a welcoming environment for medical trainees from historically underrepresented groups in medicine while improving the care of vulnerable populations. Members of the Florez Lab are agents of change.

Showing results 1 – 2 of 2

close
0.28949